Levaquin and Ofirmev drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Levaquin (levofloxacin) and Ofirmev (acetaminophen). Common drug interactions include tubulointerstitial nephritis among females and cytokine release syndrome among males.
The phase IV clinical study analyzes what interactions people have when they take Levaquin and Ofirmev. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.
What is Levaquin?
Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. eHealthMe is studying from 56,638 Levaquin users. Check the latest studies of Levaquin.
What is Ofirmev?
Ofirmev has active ingredients of acetaminophen. eHealthMe is studying from 817 Ofirmev users. Check the latest studies of Ofirmev.
16 people who take Levaquin and Ofirmev together, and have interactions are studied.

What are the common drug interactions of Levaquin and Ofirmev, by gender? *:
female:
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Renal tubular necrosis (death of kidney tubules)
- Anaemia (lack of blood)
- Diarrhoea
- Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
- Platelet count decreased
- Pyrexia (fever)
- Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
- Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
male:
- Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
- Pyrexia (fever)
- Bone marrow failure
- Bradycardia (abnormally slow heart action)
- Cytokine storm (over-protective immune response that can actually be fatal)
- Haematuria (presence of blood in urine)
- Hyperkalaemia (damage to or disease of the kidney)
- Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)
- Hypocalcaemia (levels of calcium in blood serum are abnormally low)
- Hypotension (abnormally low blood pressure)
What are the common drug interactions of Levaquin and Ofirmev, by age (0-1 to 60+)? *:
0-1:
- White blood cell count decreased
- Anaemia (lack of blood)
- Decreased appetite
- Disseminated intravascular coagulation (systemic activation of blood coagulation)
- Haemoglobin decreased
- Hydrocele
- Hypertension (high blood pressure)
- Hypoxia (low oxygen in tissues)
- Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
- Pancreatitis (inflammation of pancreas)
2-9:
n/a
10-19:
- Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
- Blood creatinine increased
- Blood lactic acid increased
- Blood urea increased
- Bone marrow failure
- Bradycardia (abnormally slow heart action)
- Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
- Cytokine storm (over-protective immune response that can actually be fatal)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Haematuria (presence of blood in urine)
20-29:
n/a
30-39:
n/a
40-49:
- Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
- Back pain
- Depression
- Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
- Neoplasm progression (growth of tumour)
- Neuropathy peripheral (surface nerve damage)
- Pulmonary embolism (blockage of the main artery of the lung)
- Subgaleal haematoma (bleeding in the potential space between the skull periosteum and the scalp galea aponeurosis)
- Upper respiratory tract infection
50-59:
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Cardiac arrest
- Thermal burn (burn by heat)
- Respiratory failure (inadequate gas exchange by the respiratory system)
60+:
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Renal tubular necrosis (death of kidney tubules)
- Chronic kidney disease
- Fungaemia (fungi circulate in the blood)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Rectal haemorrhage (bleeding from anus)
- Renal failure (kidney dysfunction)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
- Anaemia (lack of blood)
- Diarrhoea
What are the existing conditions these people have? *
- Bone Marrow Conditioning Regimen: 5 people, 31.25%
- Diffuse Large B-Cell Lymphoma Refractory (cancer of b cells, a type of white blood cell-relapsed): 5 people, 31.25%
- Febrile Neutropenia (fever with reduced white blood cells): 5 people, 31.25%
- High Blood Pressure: 4 people, 25.00%
- Pain: 4 people, 25.00%
- Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 4 people, 25.00%
- Diarrhea: 3 people, 18.75%
- Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 3 people, 18.75%
- Interleukin Level Increased: 3 people, 18.75%
- Constipation: 3 people, 18.75%
* Approximation only. Some reports may have incomplete information.
Do you take Levaquin and Ofirmev?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Levaquin and Ofirmev:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Levaquin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ofirmev:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Levaquin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ofirmev and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
- MITTAL V, ARCHANA D, GUPTA A, SRIVASTAV U, CHANDRA V, SAXENA A, AGRAWAL P, "Aphasia: a Rarest Complication with a Well Known Drug Levofloxacin", Medical Science, 2013 Jan .
- Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
- MITTAL V, ARCHANA D, GUPTA A, SRIVASTAV U, CHANDRA V, SAXENA A, AGRAWAL P, "Aphasia: a Rarest Complication with a Well Known Drug Levofloxacin", Medical Science, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on levofloxacin and acetaminophen (the active ingredients of Levaquin and Ofirmev, respectively), and Levaquin and Ofirmev (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Echinacea cause Arthritis? - a second ago
- Drug interactions of Amaryl and Astelin - 2 seconds ago
- Drug interactions of Protonix and Tukysa - 2 seconds ago
- Could Albuterol cause Mental Status Changes? - 21 seconds ago
- Drug interactions of Cozaar and Exidine - 23 seconds ago
- Could Alphagan cause Paleness? - 30 seconds ago
- Could Lactulose cause Endometrial Cancer? - 33 seconds ago
- Drug interactions of Selenium Sulfide and Metformin - 34 seconds ago
- Could Normodyne cause Gastritis? - 37 seconds ago
- Could Seroquel cause Chronic Kidney Disease? - 37 seconds ago